
Macmika 250mg Injection
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Amikacin (250mg)
Overview Macmika 250mg Injection
Cefamika 250mg Injection combats a broad spectrum of bacterial infections, offering preventative and treatment benefits for conditions affecting various bodily systems, including the urinary tract, skeletal system, respiratory system (like pneumonia), central nervous system, and circulatory system. Prophylactic use is also indicated in hospitalized patients. This antibiotic functions by inhibiting bacterial proliferation. Administration, strictly under medical guidance, occurs via intravenous infusion or intramuscular injection. Consistent, evenly spaced dosing, as directed, is crucial; premature cessation can result in recurrence or exacerbation of the infection. Commonly reported adverse effects encompass injection site reactions and elevated blood urea nitrogen. Persistent side effects or treatment inefficacy necessitate immediate medical consultation. High-dose regimens may exceptionally lead to vertigo, nephrotoxicity, and ototoxicity. Consequently, adherence to prescribed guidelines is paramount, potentially including regular monitoring of renal function, hearing acuity, and urine analysis. Pregnancy contraindicates the use of this medication; disclose pregnancy, pregnancy intentions, or breastfeeding status to your physician.
Uses of Macmika 250mg Injection
Infections caused by bacteria
Major Benefits of Macmika 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Macmika 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Macmika 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Macmika 250mg Injection works:
Macmika 250mg Injection is a bacterial growth inhibitor, functioning as an antibiotic by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Macmika 250mg Injection may be used concurrently with alcohol without known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Macmika 250mg Injection during pregnancy poses a confirmed risk to the fetus. Its use should be strictly avoided except in exceptionally rare, life-threatening circumstances where potential benefits outweigh the known hazards, as determined by a physician. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactation is not contraindicated with Macmika 250mg Injection. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Administering Macmika 250mg Injection can induce drowsiness, blurred vision, and dizziness. Driving is contraindicated if these effects manifest.
KidneyCAUTION
Administering Macmika 250mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification of Macmika 250mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Macmika 250mg Injection in patients with liver conditions is likely safe. Available evidence indicates dose modification may be unnecessary. Physician consultation is recommended.
What if you forget to take Macmika 250mg Injection :
Should you forget a scheduled dose of Macmika 250mg Injection, seek advice from your physician.
Facts to Know About Macmika 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Behavior Class | Aminoglycoside antibiotics |
